While taking a drug to treat a condition it hasn't been approved to treat may sound sketchy, it's actually very common in the pharmaceutical world
Kubota, et al., A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice
While the research base for microdosing, specifically, is still developing, and lower-dose protocols are being explored, though clinical evidence for efficacy at sub-therapeutic doses remains limited
The reduced concentration of piperine, known for its anti-inflammatory, antioxidant, and lipid peroxidation-protective properties, has been linked to the ineffective neuroprotective characteristics observed in individuals with T21 (Parfieniuk et al
In the sham operation group, the hepatic branch was exposed but not cut
22.6% weight loss at 12 mg